Anavex Life Sciences Corp (AVXL)

[tredenwater2]

“ Blarcamesine can compliment a MAB treatment by reducing or stopping brain atrophy and shrinkage”

I agree and it appears to me that you might only need a mab in severe cases of plaque buildup, after you jump through all the other “exclusions” for the mabs.

The mabs do not work symbiotically with the body, hence the ARIAs, and our drug does so I agree, Dr Sabbagh he might be throwing them a bone until we gain approval knowing once we do, their prescriptions will be collecting dust on the shelf.